Current concepts in bacterial sexually transmitted diseases

Korean Journal of Urology

Volumn 52, Issue 9, 2011, Pages 589-597

  Shim, Bong Suk ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Chancroid; Chlamydia; Gonorrhea; Sexually transmitted diseases; Syphilis

Indexed keywords

AZITHROMYCIN; BENZATHINE PENICILLIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; OFLOXACIN; PENICILLIN G; RIFAMPICIN; SPECTINOMYCIN; SULFONAMIDE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANUS PRURITUS; ARTICLE; CELL CULTURE; CHLAMYDIA TRACHOMATIS; CHLAMYDIAL URETHRITIS; CHLAMYDIASIS; CONTINUOUS INFUSION; ENZYME IMMUNOASSAY; EPIDIDYMITIS; FOLLOW UP; GONOCOCCAL URETHRITIS; GONORRHEA; HAEMOPHILUS DUCREYI; HETEROSEXUAL MALE; HUMAN; MALE HOMOSEXUAL; NEISSERIA GONORRHOEAE; NEUROSYPHILIS; PHARYNGITIS; POLYMERASE CHAIN REACTION; PROCTITIS; REITER SYNDROME; RHINOPHARYNGITIS; SECONDARY SYPHILIS; SINGLE DRUG DOSE; SYPHILIS; TREPONEMA PALLIDUM; ULCUS MOLLE; UTERINE CERVICITIS;

EID: 84930480791     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2011.52.9.589     Document Type: Article

References (96)

1. Aral S, Over M, Manhart L, Holmes KK. Sexually transmitted infections. In: Jamison D, Evans D, Alleyne G, Jha P, Breman J, Measham A, editors. Disease control priorities in developing countries. Washington, D. C: World Bank and Oxford University Press; 2006;311-30.
2. Wellings K, Collumbien M, Slaymaker E, Singh S, Hodges Z, Patel D, et al. Sexual behaviour in context: a global perspective. Lancet 2006;368:1706-28.
3. Mabey D. Epidemiology of STIs: worldwide. Am J Med 2010;38: 216-9.
4. Yeh JM, Hook EW 3rd, Golide SJ. A refined estimate of the average lifetime cost of pelvic inflammatory disease. Sex Transm Dis 2003;30:369-78.
5. Yorke JA, Hethcote HW, Nold A. Dynamics and control of the transmission of gonorrhea. Sex Transm Dis 1978;5:51-6.
6. Garnett GP, Bowden FJ. Epidemiology and control of curable sexually transmitted diseases: opportunities and problems. Sex Transm Dis 2000;27:588-99.
7. Kretzschmar M, van Duynhoven YT, Severijnen AJ. Modeling prevention strategies for gonorrhea and Chlamydia using stochastic network simulations. Am J Epidemiol 1996;144:306-17.
8. Stamm WE, Koutsky LA, Benedetti JK, Jourden JL, Brunham RC, Holmes KK. Chlamydia trachomatis urethral infections in men. Prevalence, risk factors, and clinical manifestations. Ann Intern Med 1984;100:47-51.
9. Marrazzo JM, Whittington WL, Celum CL, Handsfield HH, Clark A, Cles L, et al. Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics. Sex Transm Dis 2001;28:219-25.
10. Creighton S, Tenant-Flowers M, Taylor CB, Miller R, Low N. Co-infection with gonorrhoea and chlamydia: how much is there and what does it mean? Int J STD AIDS 2003;14:109-13.
11. Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML. The unexpected impact of a Chlamydia trachomatis control program on susceptibility to reinfection. J Infect Dis 2005;192:1836-44.
12. Barnes RC, Rompalo AM, Stamm WE. Comparison of Chlamydia trachomatis serovars causing rectal and cervical infections. J Infect Dis 1987;156:953-8.
13. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004;36:6-10.
14. McMillan A, Sommerville RG, McKie PM. Chlamydial infection in homosexual men: Frequency of isolation of Chlamydia trachomatis from the urethra, ano-rectum, and pharynx. Br J Vener Dis 1981;57:47-9.
15. Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004;291: 2229-36.
16. Quinn TC, Goodell SE, Mkrtichian E, Schuffler MD, Wang SP, Stamm WE, et al. Chlamydia trachomatis proctitis. N Engl J Med 1981;305:195-200.
17. Jones RB, Rabinovitch RA, Katz BP, Batteiger BE, Quinn TS, Terho P, et al. Chlamydia trachomatis in the pharynx and rectum of heterosexual patients at risk for genital infection. Ann Intern Med 1985;102:757-62.
18. Lyss SB, Kamb ML, Peterman TA, Moran JS, Newman DR, Bolan G, et al. Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States. Ann Intern Med 2003;139: 178-85.
19. Korenromp EL, Sudaryo MK, de Vlas SJ, Gray RH, Sewankambo NK, Serwadda D, et al. What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? Int J STD AIDS 2002;13: 91-101.
20. Handsfield HH, Alexander ER, Pin Wang S, Pedersen AH, Holmes KK. Differences in the therapeutic response of chlamydia positive and chlamydia-negative forms of nongonococcal urethritis. J Am Vener Dis Assoc 1976;2:5-9.
21. Hillis SD, Coles FB, Litchfield B, Black CM, Mojica B, Schmitt K, et al. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. A use-effectiveness study in public health settings. Sex Transm Dis 1998;25:5-11.
22. Schafer MA, Schachter J, Moncada J, Keogh J, Pantell R, Gourlay L, et al. Evaluation of urine based screening strategies to detect Chlamydia trachomatis among sexually active asymptomatic young males. JAMA 1993;270:2065-70.
23. Oriel JD, Reeve P, Thomas BJ, Nicol CS. Infection with Chlamydia group A in men with urethritis due to Neisseria gonorrhoeae. J Infect Dis 1975;131:376-82.
24. Holmes KK, Handsfield HH, Wang SP, Wentworth BB, Turck M, Anderson JB, et al. Etiology of nongonococcal urethritis. N Engl J Med 1975;292:1199-205.
25. Berger RE, Alexander ER, Harnisch JP, Paulsen CA, Monda GD, Ansell J, et al. Etiology, manifestations and therapy of acute epididymitis: Prospective study of 50 cases. J Urol 1979;121:750-4.
26. Kousa M, Saikku P, Richmond S, Lassus A. Frequent association of chlamydial infection with Reiter's syndrome. Sex Transm Dis 1978;5:57-61.
27. Paavonen J, Stevens CE, Wølner-Hanssen P, Critchlow CW, Derouen T, Kiviat N, et al. Colposcopic manifestations of cervical and vaginal infections. Obstet Gynecol Surv 1988;43:373-81.
28. Brunham RC, Paavonen J, Stevens CE, Kiviat N, Kuo CC, Critchlow CW, et al. Mucopurulent cervicitis-the ignored counterpart in women of urethritis in men. N Engl J Med 1984;311:1-6.
29. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997;10:160-84.
30. Marrazzo JM, Stamm WE. New approaches to the diagnosis, treatment, and prevention of chlamydial infection. Curr Clin Top Infect Dis 1998;18:37-59.
31. Bauwens JE, Clark AM, Loeffelholz MJ, Herman SA, Stamm WE. Diagnosis of Chlamydia trachomatis urethritis in men by polymerase chain reaction assay of first-catch urine. J Clin Microbiol 1993;31:3013-6.
32. Bianchi A, Scieux C, Brunat N, Vexiau D, Kermanach M, Pezin P, et al. An evaluation of the polymerase chain reaction amplicor Chlamydia trachomatis in male urine and female urogenital specimens. Sex Transm Dis 1994;21:196-200.
33. Arya OP, Hobson D, Hart CA, Bartzokas C, Pratt BC. Evaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal chlamydial, and non-specific urethritis in men. Genitourin Med 1986;62:170-4.
34. Hooton TM, Batteiger BE, Judson FN, Spruance SL, Stamm WE. Ofloxacin versus Doxycycline for treatment of cervical infection with Chlamydia trachomatis. Antimicrob Agents Chemother 1992;36:1144-6.
35. Ossewaarde JM, Plantema FH, Rieffe M, Nawrocki RP, de Vries A, van Loon AM. Efficacy of single-dose azithromycin versus doxycycline in the treatment of cervical infections caused by Chlamydia trachomatis. Eur J Clin Microbiol Infect Dis 1992;11:693-7.
36. Bowie WR, Alexander ER, Stimson JB, Floyd JF, Holmes KK. Therapy for nongonococcal urethritis: Double-blind randomized comparison of two doses and two durations of minocycline. Ann Intern Med 1981;95:306-11.
37. Prentice MJ, Taylor-Robinson D, Csonka GW. Non-specific urethritis: A placebo-controlled trial of minocycline in conjunction with laboratory investigations. Br J Vener Dis 1976;52:269-75.
38. Morton R. Gonorrhoea, Vol. 9 in the series Major Problems in Dermatology. In: Rook A. London: W.B. Saunders; 1977.
39. Rosebury T. Microbes and morals: the strange story of venereal disease. New York: Viking Adult, 1971.
40. Kampmeier RH. Identification of the gonococcus by Albert Neisser. Sex Transm Dis 1978;5:71-2.
41. Kampmeier RH. Introduction of sulfonamide therapy for gonorrhea. Sex Transm Dis 1983;10:81-4.
42. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women; results from a cohort study. AIDS 1993;7:95-102.
43. Memish ZA, Osoba AO. Sexually transmitted diseases and travel. Int J Antimicrob Agents 2003;21:131-4.
44. Fenton KA, Lowndes CM. Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm Infect 2004;80:255-63.
45. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Surveillance, 2005. Atlanta, GA; U.S. Department of Health and Human Services, Public Health Service, Nov. 2006.
46. 2006 World Health Organization. CISID database. Sexually transmitted infections. http://data.euro.who.int/cisid/default. aspx?TabID=123064. Accessed March 28, 2007.
47. Barnes RC, Holmes KK. Epidemiology of gonorrhea: Current perspectives. Epidemiol Rev 1984;6:1-30.
48. Lafferty WE, Hughes JP, Handsfield HH. Sexually transmitted disease in men who have sex with men: Acquisition of gonorrhea and nongonococcal urethritis by fellatio and implications for STD/HIV prevention. Sex Transm Dis 1997;24:272-8.
49. Kellogg DS Jr, Peacock WL Jr, Deacon WE, Brown L, Pirkle DI. Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation. J Bacteriol 1963;85:1274-9.
50. Bruins SC, Tight RR. Laboratory-acquired gonococcal conjunctivitis. JAMA 1979;241:274.
51. Pearce WA, Buchanan TM. Attachment role of gonococcal pili: Optimum conditions and quantitation of adherence of isolated pili to human cells in vitro. J Clin Invest 1978;61:931-43.
52. King GJ, Swanson J. Studies on gonococcus infection. XV. Identification of surface proteins of Neisseria gonorrhoeae correlated with leukocyte association. Infect Immun 1978;21:575-84.
53. Holmes KK, Johnson DW, Trostle HJ. An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females. Am J Epidemiol 1970;91:170-4.
54. Hooper RR, Reynolds GH, Jones OG, Zaidi A, Wiesner PJ, Latimer KP, et al. Cohort study of venereal disease: 1. The risk of gonorrhea transmission from infected women to men. Am J Epidemiol 1978;108:136-44.
55. Tice RW, Rodriguez VL. Pharyngeal gonorrhea. JAMA 1981;246: 2717-9.
56. Handsfield HH, Lipman TO, Harnisch JP, Tronca E, Holmes KK. Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significance. N Engl J Med 1974;290:117-23.
57. Robinson AJ, Ridgway GL. Concurrent gonococcal and chlamydial infection: how best to treat. Drugs 2000;59:801-13.
58. Harrison WO, Hooper RR, Wiesner PJ, Campbell AF, Karney WW, Reynolds GH, et al. A trial of minocycline given after exposure to prevent gonorrhea. N Engl J Med 1979;300:1074-8.
59. Jacobs NF, Kraus SJ. Gonococcal and nongonococcal urethritis in men: Clinical and laboratory differentiation. Ann Intern Med 1975;82:7-12.
60. Barlow D, Phillips I. Gonorrhea in women: Diagnostic, clinical, and laboratory aspects. Lancet 1978;1:761-4.
61. Platt R, Rice PA, McCormack WM. Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea. JAMA 1983;250:320-9.
62. Curran JW, Rendtorff RC, Chandler RW, Wiser WL, Robinson H. Female gonorrhea: Its relation to abnormal uterine bleeding, urinary tract symptoms, and cervicitis. Obstet Gynecol 1975;45: 195-8.
63. Lebedeff DA, Hochman EB. Rectal gonorrhea in men: Diagnosis and treatment. Ann Intern Med 1980;92:463-6.
64. Wiesner PJ, Tronca E, Bonin P, Pedersen AH, Holmes KK. Clinical spectrum of pharyngeal gonococcal infections. N Engl J Med 1973;288:181-5.
65. Hutt DM, Judson FN. Epidemiology and treatment of oropharyngeal gonorrhea. Ann Intern Med 1986;104:655-8.
66. Johnson RE, Newhall WJ, Papp JR, Knapp JS, Black CM, Gift TL, et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections-2002. MMWR Recomm Rep 2002;51:1-38.
67. Cook RL, Hutchison SL, Østergaard L, Braithwaite RS, Ness RB. Systematic review: Noninvasive testing for chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005;142:914-25.
68. Koumans EH, Johnson RE, Knapp JS, St Louis ME. Laboratory testing for Neisseria gonorrhoeae by recently introduced nonculture tests: a performance review with clinical and public health considerations. Clin Infect Dis 1998;27:1171-80.
69. Davies PO, Low N, Ison CA. The role of effective diagnosis for the control of gonorrhoea in high prevalence populations. Int J STD AIDS 1998;9:435-43.
70. Boslego JW, Tramont EC, Takafuji ET, Diniega BM, Mitchell BS, Small JW, et al. Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med 1987;317:272-8.
71. Burstein GR, Berman SM, Blumer JL, Moran JS. Ciprofloxacin for the treatment of uncomplicated gonorrhea infection in adolescents: does the benefit outweigh the risk? Clin Infect Dis 2002;35(suppl 2):191-9.
72. Handsfield HH, Dalu ZA, Martin DH, Douglas JM Jr, McCarty JM, Schlossberg D. Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromyclin Gonorrhea Study Group. Sex Transm Dis 1994;21: 107-11.
73. Paster BJ, Dewhirst FE. Phylogenetic foundation of spirochetes. J Mol Microbiol Biotechnol 2000;2:341-4.
74. Garnett GP, Aral SO, Hoyle DV, Cates W Jr, Anderson RM. The natural history of syphilis. Implications for the transmission dynamics and control of infection. Sex Transm Dis 1997;24:185-200
75. Klausner JD, Wolf W, Fischer-Ponce L, Zolt I, Katz MH. Tracing a syphilis outbreak through cyberspace. JAMA 2000;284:447-9
76. Ratnam S. The laboratory diagnosis of syphilis. Can J Infect Dis Med Microbiol 2005;16:45-51.
77. Nandwani R, Evans DT. Are you sure it's syphilis? A review of false positive serology. Int J STD AIDS 1995;6:241-8.
78. Romanowski B, Sutherland R, Fick GH, Mooney D, Love EJ. Serologic response to treatment of infectious syphilis. Ann Intern Med 1991;114:1005-9.
79. Mackay IM, Harnett G, Jeoffreys N, Bastian I, Sriprakash KS, Siebert D, et al. Detection and discrimination of herpes simplex viruses, Haemophilus ducreyi, Treponema pallidum, and Calymmatobacterium (Klebsiella) granulomatis from genital ulcers. Clin Infect Dis 2006;42:1431-8.
80. Turner TB, Hardy PH, Newman B. Infectivity tests in syphilis. Br J Vener Dis 1969;45:183-95.
81. Bauer TJ, Price EV, Cutler JC. Spinal fluid examinations among patients with primary or secondary syphilis. Am J Syph 1952;36:309-18.
82. Hook EW 3rd, Marra CM. Acquired syphilis in adults. N Engl J Med 1992;326:1060-9.
83. Rolfs RT, Joesoef MR, Hendershot EF, Rompalo AM, Augenbraun MH, Chiu M, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med 1997;337:307-14.
84. Golden MR, Marra CM, Holmes KK. Update on syphilis: resurgence of an old problem. JAMA 2003;290:1510-4.
85. Brown ST. Adverse reactions in syphilis therapy. J Am Vener Dis Assoc 1976;3:172-6.
86. Zhou P, Gu Z, Xu J, Wang X, Liao K. A study evaluating ceftriaxone as a treatment agent for primary and secondary syphilis in pregnancy. Sex Transm Dis 2005;32:495-8.
87. Ghanem KG, Erbelding EJ, Cheng WW, Rompalo AM. Doxycycline compared with benzathine penicillin for the treatment of early syphilis. Clin Infect Dis 2006;42:e45-9.
88. Riedner G, Rusizoka M, Todd J, Maboko L, Hoelscher M, Mmbando D, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 2005;353:1236-44.
89. Lukehart SA. Serologic testing after therapy for syphilis: is there a test for cure? Ann Intern Med 1991;114:1057-8.
90. Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007;83:97-101.
91. Centers for Disease Control and Prevention. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006;55:1-94.
92. Morse SA. Chancroid and Haemophilus ducreyi. Clin Microbiol Rev 1989;2:137-57.
93. Hammond GW, Slutchuk M, Scatliff J, Sherman E, Wilt JC, Ronald AR. Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America. Rev Infect Dis 1980;2:867-79.
94. Lewis D. Chancroid: clinical manifestations, diagnosis and management. Sex Transm Infect 2003;79:68-71.
95. Tyndall MW, Agoki E, Plummer FA, Malisa W, Ndinya-Achola JO, Ronald AR. Single dose azithromycin for the treatment of chancroid: a randomized comparison with erythromycin. Sex Transm Dis 1994;21:231-4.
96. Martin DH, Sargent SJ, Wendel GD Jr, McCormack WM, Spier NA, Johnson RB. Comparison of azithromycin and ceftriaxone for the treatment of chancroid. Clin Infect Dis 1995;21:409-14.